Tag Archives: endocannabinoid

Therapeutic utility of the endocannabinoid system in demyelinating diseases The demyelinating diseases are medical conditions in which the main pathogenic process is directed against the myelin sheath covering the axons of neurons and enables proper conduction of nerve impulses. The most frequent demyelinating disease is multiple sclerosis (MS), which is characterized by a decrease in […]